Appointment of Chief Operating Officer
Perth, Aug 15, 2016 AEST (ABN Newswire) - MMJ PhytoTech Limited (
ASX:MMJ) ("MMJ" or "the Company") is pleased to advise that Catherine Harvey has been appointed as Chief Operations Officer, effective 1 September 2016.
In the role of Chief Operations Officer, Catherine will play a significant role in overseeing the daily operations of MMJ's key business divisions, with a focus on the execution of key international growth objectives. Catherine will be based in Sydney and will work closely with MMJ's senior management team to design and deliver MMJ's commercial and regulatory strategy, with a focus on the Australian market, but also overseeing MMJ's international operations.
Catherine is a highly experienced pharmaceutical industry executive, with an extensive corporate background, having worked for multiple pharmaceutical organisations both domestically and overseas. Most recently, Catherine held executive leadership positions including Director of Business Development and Corporate Affairs at Mundipharma Pty Limited and Business Development Manager at Norwegian Pharmaceutical company, Nycomed.
Throughout her career to date, Catherine has established a strong track record in the implementation of successful commercialisation strategies and strategic planning at senior management level.
MMJ's Managing Director, Andreas Gedeon, commented on the appointment, "We are very pleased to be welcoming someone of Catherine's calibre to the management team, during this exciting period in our evolution as a leading vertically integrated medical cannabis business.
Catherine's extensive pharmaceutical industry experience, in particular her ability to drive commercial strategies and sales growth, will be a tremendous addition to the team and will provide MMJ with the requisite bench strength to build upon our robust foundations as we look to capitalise on a number of near-term growth opportunities."
As part of Catherine's remuneration package, the Company has agreed to grant her 3,000,000 unlisted options with an expiry date of 4 years from the date of issue and an exercise price equal to the 5 day VWAP of the underlying MMJ shares traded on the ASX immediately prior to the commencement of her employment on 1 September 2016. The options will vest in equal thirds every 12 months, subject to Catherine's ongoing employment with the Company.
About MMJ Group Holdings Ltd
MMJ Group Holdings Ltd (ASX:MMJ) is a global cannabis investment company. MMJ owns a portfolio of minority investments and aims to invest across the full range of emerging cannabis-related sectors including healthcare, technology, infrastructure, logistics, processing, cultivation, equipment and retail. For MMJ's latest investor presentation and news, please visit: https://www.mmjphytotech.com.au/investors/
| ||
|
